No valuation for Inhal Pharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($29.5M) and the funding record below are the closest available signals.
- ·The complete investor list: 13 names
- ·Watch Inhal Pharma: the Monday email on marks, rounds and moves
Inhal Pharma funding history
No funding rounds for Inhal Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Inhal Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Inhal Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Inhal Pharma
- How much has Inhal Pharma raised?
- Inhal Pharma has raised $29.5M in total funding across its recorded rounds.